Response to Dr. Markman regarding "Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials Article Letter uri icon

Overview

MeSH Major

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Immunotherapy, Adoptive
  • Ovarian Neoplasms

publication date

  • March 2008

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2007.11.030

PubMed ID

  • 18201751

Additional Document Info

start page

  • 658; author reply 658

end page

  • 9

volume

  • 108